Solid Tumor second primary neoplasms: Who is at risk, what can we do?

Seminars in Oncology

Volumn 40, Issue 6, 2013, Pages 676-689

  Oeffinger, Kevin C ^a   Baxi, Shrujal S ^a   Novetsky Friedman, Danielle ^a   Moskowitz, Chaya S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DNA; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; RETINOBLASTOMA PROTEIN; TAMOXIFEN;

AGING; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM TUMOR; CHEMOPROPHYLAXIS; CHILDHOOD CANCER; CLINICAL PRACTICE; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; DNA DAMAGE; DNA REPAIR; ESOPHAGUS CANCER; FAMILIAL CANCER; GENE MUTATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY CARCINOMA; LIFESTYLE MODIFICATION; LIVER CANCER; LOW DRUG DOSE; LUNG CANCER; LUNG CARCINOMA; MELANOMA; MISMATCH REPAIR; NON MELANOMA SKIN CANCER; OSTEOSARCOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE; RECTUM CANCER; RETINOBLASTOMA; SECOND CANCER; SKIN CANCER; SKIN EXAMINATION; SMOKING; SMOKING CESSATION; SOFT TISSUE SARCOMA; SOLID TUMOR; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; THYROID CARCINOMA; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS, ALKYLATING; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COLORECTAL NEOPLASMS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HODGKIN DISEASE; HUMANS; MALE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; NEOPLASTIC SYNDROMES, HEREDITARY; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SKIN NEOPLASMS; SMOKING; STOMACH NEOPLASMS; THYROID NEOPLASMS; UNITED STATES;

EID: 84890373465     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2013.09.012     Document Type: Article

References (122)

1. Howlader N, Noone AM, Krapcho M, et al (eds). SEER cancer statistics review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer. gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER website, April 2013.
2. Travis LB, Bhatia S, Allan JM, et al (eds). Cancer: principles and practice of oncology. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011
3. G.B. Hutchison Late neoplastic changes following medical irradiation Cancer 37 1976 1102 1110
4. G.M. Dores, C. Metayer, and R.E. Curtis Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years J Clin Oncol 20 2002 3484 3494
5. S. Bhatia, L.L. Robison, and O. Oberlin Breast cancer and other second neoplasms after childhood Hodgkin's disease N Engl J Med 334 1996 745 751
6. S. Bhatia, Y. Yasui, and L.L. Robison High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group J Clin Oncol 21 2003 4386 4394
7. A.J. Sigurdson, C.M. Ronckers, and A.C. Mertens Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study Lancet 365 2005 2014 2023
8. L.B. Travis, R.E. Curtis, and B. Glimelius Second cancers among long-term survivors of non-Hodgkin's lymphoma J Natl Cancer Inst 85 1993 1932 1937
9. R.C. Reulen, C. Frobisher, and D.L. Winter Long-term risks of subsequent primary neoplasms among survivors of childhood cancer JAMA 305 2011 2311 2319
10. D.L. Friedman, J. Whitton, and W. Leisenring Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study J Natl Cancer Inst 102 2010 1083 1095
11. A.K. Chaturvedi, E.A. Engels, and E.S. Gilbert Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk J Natl Cancer Inst 99 2007 1634 1643
12. N.N. Baxter, J.E. Tepper, S.B. Durham, D.A. Rothenberger, and B.A. Virnig Increased risk of rectal cancer after prostate radiation: a population-based study Gastroenterology 128 2005 819 824
13. L.B. Travis, S.D. Fossa, and S.J. Schonfeld Second cancers among 40,576 testicular cancer patients: focus on long-term survivors J Natl Cancer Inst 97 2005 1354 1365
14. L.B. Travis, D.A. Hill, and G.M. Dores Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475
15. L.M. Morton, E.S. Gilbert, and P. Hall Risk of treatment-related esophageal cancer among breast cancer survivors Ann Oncol 23 2012 3081 3091
16. A. Berrington de Gonzalez, R.E. Curtis, and S.F. Kry Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries Lancet Oncol 12 2011 353 360
17. T. Pickles, and N. Phillips The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000 Radiother Oncol 65 2002 145 151
18. J.D. Boice Jr., G. Engholm, and R.A. Kleinerman Radiation dose and second cancer risk in patients treated for cancer of the cervix Radiat Res 116 1988 3 55
19. S.L. Hancock, M.A. Tucker, and R.T. Hoppe Breast cancer after treatment of Hodgkin's disease J Natl Cancer Inst 85 1993 25 31
20. L.S. Constine, N. Tarbell, and M.M. Hudson Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose Int J Radiat Oncol Biol Phys 72 2008 24 33
21. M.L. De Bruin, J. Sparidans, and M.B. van't Veer Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes J Clin Oncol 27 2009 4239 4246
22. C. Guibout, E. Adjadj, and C. Rubino Malignant breast tumors after radiotherapy for a first cancer during childhood J Clin Oncol 23 2005 197 204
23. P.D. Inskip, L.L. Robison, and M. Stovall Radiation dose and breast cancer risk in the Childhood Cancer Survivor Study J Clin Oncol 27 2009 3901 3907
24. L.B. Kenney, Y. Yasui, and P.D. Inskip Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study Ann Intern Med 141 2004 590 597
25. A. Collins, and V. Harrington Repair of oxidative DNA damage: assessing its contribution to cancer prevention Mutagenesis 17 2002 489 493
26. A.J. Taylor, D.L. Winter, and C.A. Stiller Risk of breast cancer in female survivors of childhood Hodgkin's disease in Britain: a population-based study Int J Cancer 120 2007 384 391
27. F.E. van Leeuwen, W.J. Klokman, and M. Stovall Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease J Natl Cancer Inst 95 2003 971 980
28. S. Bhatia, K. Ramsay, and M. Steinbuch Malignant neoplasms following bone marrow transplantation Blood 87 1996 3633 3639
29. L.B. Travis, D. Hill, and G.M. Dores Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma J Natl Cancer Inst 97 2005 1428 1437
30. A.J. Swerdlow, R. Cooke, and A. Bates Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study J Clin Oncol 30 2012 2745 2752
31. T.O. Henderson, A. Amsterdam, and S. Bhatia Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer Ann Intern Med 152 2010 444 455
32. C.B. Begg, R.W. Haile, and A. Borg Variation of breast cancer risk among BRCA1/2 carriers JAMA 299 2008 194 201
33. E.S. Koh, T.H. Tran, and M. Heydarian A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk Radiat Oncol 2 2007 13
34. E.B. Elkin, M.L. Klem, and A.M. Gonzales Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study J Clin Oncol 29 2011 2466 2473
35. G. Sanna, K. Lorizzo, and N. Rotmensz Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors Ann Oncol 18 2007 288 292
36. R.A. Kleinerman, S.A. Smith, and E. Holowaty Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer Int J Radiat Oncol Biol Phys 86 2013 922 929
37. A.W. van den Belt-Dusebout, B.M. Aleman, and G. Besseling Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy Int J Radiat Oncol Biol Phys 75 2009 1420 1429
38. L.M. Morton, G.M. Dores, and R.E. Curtis Stomach cancer risk after treatment for Hodgkin lymphoma J Clin Oncol 31 2013 3369 3377
39. T.O. Henderson, K.C. Oeffinger, and J. Whitton Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study Ann Intern Med 156 2012 757 766
40. A.J. Taylor, A.P. Croft, and A.M. Palace Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study Int J Cancer 125 2009 2400 2405
41. J.L. Perkins, Y. Liu, and P.A. Mitby Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study J Clin Oncol 23 2005 3733 3741
42. T.C. Watt, P.D. Inskip, and K. Stratton Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study J Natl Cancer Inst 104 2012 1240 1250
43. F. Levi, R. Moeckli, and L. Randimbison Skin cancer in survivors of childhood and adolescent cancer Eur J Cancer 42 2006 656 659
44. L.A. Daniels, A.D. Krol, and M. Schaapveld Long-term risk of secondary skin cancers after radiation therapy for Hodgkin's lymphoma Radiother Oncol 2013 Aug 7. S0167-8140 [Epub ahead of print]
45. A.K. Ng, M.V. Bernardo, and E. Weller Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors Blood 100 2002 1989 1996
46. K.I. Braam, A. Overbeek, and G.J. Kaspers Malignant melanoma as second malignant neoplasm in long-term childhood cancer survivors: a systematic review Pediatr Blood Cancer 58 2012 665 674
47. A.S. Pappo, G.T. Armstrong, and W. Liu Melanoma as a subsequent neoplasm in adult survivors of childhood cancer: a report from the childhood cancer survivor study Pediatr Blood Cancer 60 2013 461 466
48. J. Decker, and J.C. Goldstein Risk factors in head and neck cancer N Engl J Med 306 1982 1151 1155
49. B. Rodu, and C. Jansson Smokeless tobacco and oral cancer: a review of the risks and determinants Crit Rev Oral Biol Med 15 2004 252 263
50. F.R. Khuri, E.S. Kim, and J.J. Lee The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the Head and Neck Retinoid Chemoprevention Trial Cancer Epidemiol Biomarkers Prev 10 2001 823 829
51. L.G. Morris, A.G. Sikora, S.G. Patel, R.B. Hayes, and I. Ganly Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer J Clin Oncol 29 2011 739 746
52. X. Leon, M. Quer, S. Diez, C. Orus, A. Lopez-Pousa, and J. Burgues Second neoplasm in patients with head and neck cancer Head Neck 21 1999 204 210
53. E.M. Sturgis, and R.H. Miller Second primary malignancies in the head and neck cancer patient Ann Otol Rhinol Laryngol 104 1995 946 954
54. J.L. Gluckman, and J.D. Crissman Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract Laryngoscope 93 1983 71 74
55. E. Panosetti, B. Luboinski, G. Mamelle, and J.M. Richard Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study Laryngoscope 99 1989 1267 1273
56. D.P. Slaughter, H.W. Southwick, and W. Smejkal Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 1953 963 968
57. F.R. Khuri, E.S. Kim, and J.J. Lee The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial Cancer Epidemiol Biomarkers Prev 10 2001 823 829
58. S.-C. Chuang, G. Scelo, and J.M. Tonita Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries Int J Cancer 123 2008 2390 2396
59. E. Broaddus, A. Topham, and A.D. Singh Survival with retinoblastoma in the USA: 1975-2004 Br J Ophthalmol 93 2009 24 27
60. R.A. Kleinerman, M.A. Tucker, and R.E. Tarone Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up J Clin Oncol 23 2005 2272 2279
61. T. Marees, A.C. Moll, and S.M. Imhof Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up J Natl Cancer Inst 100 2008 1771 1779
62. F.L. Wong, J.D. Boice Jr., and D.H. Abramson Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk JAMA 278 1997 1262 1267
63. D.H. Abramson, M.R. Melson, I.J. Dunkel, and C.M. Frank Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma Ophthalmology 108 2001 1868 1876
64. O. Fletcher, D. Easton, and K. Anderson Lifetime risks of common cancers among retinoblastoma survivors J Natl Cancer Inst 96 2004 357 363
65. C.L. Yu, M.A. Tucker, and D.H. Abramson Cause-specific mortality in long-term survivors of retinoblastoma J Natl Cancer Inst 101 2009 581 591
66. K.E. Nichols, D. Malkin, and J.E. Garber Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers Cancer Epidemiol Biomarkers Prev 10 2001 83 87
67. F.P. Li, J.F. Fraumeni Jr., and J.J. Mulvihill A cancer family syndrome in twenty-four kindreds Cancer Res 48 1988 5358 5362
68. D. Malkin, K.W. Jolly, and N. Barbier Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms N Engl J Med 326 1992 1309 1315
69. M. Hisada, J.E. Garber, C.Y. Fung, J.F. Fraumeni Jr., and F.P. Li Multiple primary cancers in families with Li-Fraumeni syndrome J Natl Cancer Inst 90 1998 606 611
70. A. Chompret, L. Brugieres, and M. Ronsin P53 germline mutations in childhood cancers and cancer risk for carrier individuals Br J Cancer 82 2000 1932 1937
71. R.A. Kleinerman Radiation-sensitive genetically susceptible pediatric sub-populations Pediatr Radiol 39 SUPPL. 1 2009 S27 S31
72. H.T. Lynch, P.M. Lynch, W.A. Albano, and J.F. Lynch The cancer family syndrome: a status report Dis Colon Rectum 24 1981 311 322
73. J.R. Jass Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term World J Gastroenterol 12 2006 4943 4950
74. H.T. Lynch, and A. de la Chapelle Hereditary colorectal cancer N Engl J Med 348 2003 919 932
75. A.K. Win, N.M. Lindor, and J.P. Young Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome J Natl Cancer Inst 104 2012 1363 1372
76. T. Goecke, K. Schulmann, and C. Engel Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium J Clin Oncol 24 2006 4285 4292
77. J.H. Hoeijmakers DNA damage, aging, and cancer N Engl J Med 361 2009 1475 1485
78. T. Best, D. Li, and A.D. Skol Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma Nat Med 17 2011 941 943
79. A. Broeks, L.M. Braaf, and L.F. Wessels Radiation-associated breast tumors display a distinct gene expression profile Int J Radiat Oncol Biol Phys 76 2010 540 547
80. L.B. Travis, M. Gospodarowicz, and R.E. Curtis Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease J Natl Cancer Inst 94 2002 182 192
81. K.C. Oeffinger, A.C. Mertens, and C.A. Sklar Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study J Clin Oncol 21 2003 1359 1365
82. E.G. Garmey, Q. Liu, and C.A. Sklar Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study J Clin Oncol 26 2008 4639 4645
83. P.M. Janiszewski, K.C. Oeffinger, and T.S. Church Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia J Clin Endocrinol Metab 92 2007 3816 3821
84. T.A. Florin, G.E. Fryer, and T. Miyoshi Physical inactivity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study Cancer Epidemiol Biomarkers Prev 16 2007 1356 1363
85. W. Chemaitilly, A.C. Mertens, and P. Mitby Acute ovarian failure in the childhood cancer survivor study J Clin Endocrinol Metab 91 2006 1723 1728
86. C.A. Sklar, A.C. Mertens, and P. Mitby Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study J Natl Cancer Inst 98 2006 890 896
87. R.E. Harris, K.K. Namboodiri, and E.L. Wynder Breast cancer risk: effects of estrogen replacement therapy and body mass J Natl Cancer Inst 84 1992 1575 1582
88. Z. Huang, S.E. Hankinson, and G.A. Colditz Dual effects of weight and weight gain on breast cancer risk JAMA 278 1997 1407 1411
89. L.M. Morimoto, E. White, and Z. Chen Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) Cancer Causes Control 13 2002 741 751
90. M. Harvie, L. Hooper, and A.H. Howell Central obesity and breast cancer risk: a systematic review Obes Rev 4 2003 157 173
91. H.R. Harris, W.C. Willett, K.L. Terry, and K.B. Michels Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II J Natl Cancer Inst 103 2011 273 278
92. C.M. Friedenreich, K.S. Courneya, and H.E. Bryant Influence of physical activity in different age and life periods on the risk of breast cancer Epidemiology 12 2001 604 612
93. E.M. Monninkhof, S.G. Elias, and F.A. Vlems Physical activity and breast cancer: a systematic review Epidemiology 18 2007 137 157
94. R. Mody, S. Li, and D.C. Dover Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study Blood 111 2008 5515 5523
95. W.B. Kannel The Framingham study Br Med J 2 1976 1255
96. W.B. Kannel, D. McGee, and T. Gordon A general cardiovascular risk profile: the Framingham Study Am J Cardiol 38 1976 46 51
97. P.W. Wilson, W.P. Castelli, and W.B. Kannel Coronary risk prediction in adults (the Framingham Heart Study) Am J Cardiol 59 1987 91G 94G
98. S.M. Grundy, G.J. Balady, and M.H. Criqui Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association Circulation 97 1998 1876 1887
99. S.C. Romero, K.M. Dela Rosa, and P.E. Linz Aspirin for primary prevention of coronary heart disease: using the Framingham Risk Score to improve utilization in a primary care clinic South Med J 101 2008 725 729
100. S.A. Lear, J.J. Spinelli, and W. Linden The Extensive Lifestyle Management Intervention (ELMI) after cardiac rehabilitation: a 4-year randomized controlled trial Am Heart J 152 2006 333 339
101. N.M. Maruthur, N.Y. Wang, and L.J. Appel Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER trial Circulation 119 2009 2026 2031
102. J.P. Costantino, M.H. Gail, and D. Pee Validation studies for models projecting the risk of invasive and total breast cancer incidence J Natl Cancer Inst 91 1999 1541 1548
103. van Leeuwen FE, Travis LB: Second cancers. In: Cancer: principles and practice of oncology. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:2575-602.
104. S.A. Kovalchik, C.M. Ronckers, and L.H. Veiga Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer J Clin Oncol 31 2013 119 127
105. W. Landier, S. Bhatia, and D.A. Eshelman Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline J Clin Oncol 22 2004 4979 4990
106. A.K. Ng, J.E. Garber, and L.R. Diller Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma J Clin Oncol 31 2013 2282 2288
107. Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Version 3.0. 2008. Available online: http://www.survivorshipguidelines.org/.
108. P.F. Coccia, J. Altman, and S. Bhatia Adolescent and young adult oncology. Clinical practice guidelines in oncology J Natl Compr Canc Netw 10 2012 1112 1150
109. Mulder RL, Kremer LC, Hudson MM, et al. Recommendations for breast cancer surveillance for female childhood, adolescent and young adult cancer survivors treated with chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. In press.
110. K.C. Oeffinger, J.S. Ford, and C.S. Moskowitz Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer JAMA 301 2009 404 414
111. P.C. Nathan, K.K. Ness, and M.C. Mahoney Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study Ann Intern Med 153 2010 442 451
112. M.L. Metzger, S.C. Howard, and M.M. Hudson Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma Pediatr Blood Cancer 46 2006 314 319
113. D.G. Pfister, K.-K. Ang, and D.M. Brizel Head and neck cancers J Natl Compr Canc Netw 9 2011 596 650
114. A. Agrawal, T.H. Hammond, and G.S. Young Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance Laryngoscope 119 2009 2135 2140
115. M. Boysen, K. Natvig, F.O. Winther, and J. Tausjo Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck J Otolaryngol 14 1985 211 214
116. F.E. Marchant, L.D. Lowry, J.J. Moffitt, and R. Sabbagh Current national trends in the posttreatment follow-up of patients with squamous cell carcinoma of the head and neck Am J Otolaryngol 14 1993 88 93
117. A.V. de Visscher, and J.J. Manni Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg 120 1994 934 939
118. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409
119. P.B. Bach, J.N. Mirkin, and T.K. Oliver Benefits and harms of ct screening for lung cancer: A systematic review JAMA 307 2012 2418 2429
120. P. Lao-Sirieix, and R.C. Fitzgerald Screening for oesophageal cancer Nat Rev Clin Oncol 9 2012 278 287
121. M.B. Daly Genetic/familial high-risk assessment: breast and ovarian J Natl Compr Canc Netw 8 2010 562
122. A. Villani, U. Tabori, and J. Schiffman Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study Lancet Oncol 12 2011 559 567